Search research articles
Contact Us
Filters
Showing results (91-100 of 186) with videos related to
Page
of 19
Sort By:
Local and Regional Anesthesia
|
December 12, 2019
Anesthesia for Percutaneous Radiofrequency Tumor Ablation (PRFA): A Review of Current Practice and Techniques
Federico Piccioni, Andrea Poli, Leah Carol Templeton, et al.
The New Microbiologica
|
April 21, 2020
Dynamics of HIV-1 POL antibodies after ART in chronic HIV-1 infection
Francesca Rinaldi, Serena Rolla, Laura Galli, et al.
The Journal of Antimicrobial Chemotherapy
|
November 1, 2016
Efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate as treatment for primary or recent HIV infection
Silvia Nozza, Andrea Poli, Marco Ripa, et al.
The Journal of Antimicrobial Chemotherapy
|
March 24, 2017
Efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate as treatment for primary or recent HIV infection-authors' response
Silvia Nozza, Andrea Poli, Marco Ripa, et al.
Indian Journal of Orthopaedics
|
January 19, 2023
Non-Union Scoring System (NUSS): Is It Enough in Clinical Practice?
Diego Gaddi, Simone D Gatti, Massimiliano Piatti, et al.
Nutrients
|
March 7, 2020
A randomized Placebo-Controlled Clinical Trial to Evaluate the Medium-Term Effects of Oat Fibers on Human Health: The Beta-Glucan Effects on Lipid Profile, Glycemia and inTestinal Health (BELT) Study
Arrigo F G Cicero, Federica Fogacci, Maddalena Veronesi, et al.
Therapeutics and Clinical Risk Management
|
January 1, 2014
Cost analysis of initial highly active antiretroviral therapy regimens for managing human immunodeficiency virus-infected patients according to clinical practice in a hospital setting
Giorgio L Colombo, Antonella Castagna, Sergio Di Matteo, et al.
International Journal of Antimicrobial Agents
|
May 26, 2020
Susceptibility to HIV-1 integrase strand transfer inhibitors (INSTIs) in highly treatment-experienced patients who failed an INSTI-based regimen
Maria M Santoro, Chiara Fornabaio, Marina Malena, et al.
International Journal of Antimicrobial Agents
|
July 17, 2018
Time spent with residual viraemia after virological suppression below 50 HIV-RNA copies/mL according to type of first-line antiretroviral regimen
Nicola Gianotti, Laura Galli, Nadia Galizzi, et al.
The Journal of Antimicrobial Chemotherapy
|
June 26, 2020
HIV-DNA undetectability during chronic HIV infection: frequency and predictive factors
Silvia Nozza, Laura Galli, Nicola Gianotti, et al.
Page
of 19
Search research articles
Search
Showing results (91-100 of 186) with videos related to
Sort By:
Page
of 19
Local and Regional Anesthesia
|
December 12, 2019
Anesthesia for Percutaneous Radiofrequency Tumor Ablation (PRFA): A Review of Current Practice and Techniques
Federico Piccioni, Andrea Poli, Leah Carol Templeton, et al.
The New Microbiologica
|
April 21, 2020
Dynamics of HIV-1 POL antibodies after ART in chronic HIV-1 infection
Francesca Rinaldi, Serena Rolla, Laura Galli, et al.
The Journal of Antimicrobial Chemotherapy
|
November 1, 2016
Efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate as treatment for primary or recent HIV infection
Silvia Nozza, Andrea Poli, Marco Ripa, et al.
The Journal of Antimicrobial Chemotherapy
|
March 24, 2017
Efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate as treatment for primary or recent HIV infection-authors' response
Silvia Nozza, Andrea Poli, Marco Ripa, et al.
Indian Journal of Orthopaedics
|
January 19, 2023
Non-Union Scoring System (NUSS): Is It Enough in Clinical Practice?
Diego Gaddi, Simone D Gatti, Massimiliano Piatti, et al.
Nutrients
|
March 7, 2020
A randomized Placebo-Controlled Clinical Trial to Evaluate the Medium-Term Effects of Oat Fibers on Human Health: The Beta-Glucan Effects on Lipid Profile, Glycemia and inTestinal Health (BELT) Study
Arrigo F G Cicero, Federica Fogacci, Maddalena Veronesi, et al.
Therapeutics and Clinical Risk Management
|
January 1, 2014
Cost analysis of initial highly active antiretroviral therapy regimens for managing human immunodeficiency virus-infected patients according to clinical practice in a hospital setting
Giorgio L Colombo, Antonella Castagna, Sergio Di Matteo, et al.
International Journal of Antimicrobial Agents
|
May 26, 2020
Susceptibility to HIV-1 integrase strand transfer inhibitors (INSTIs) in highly treatment-experienced patients who failed an INSTI-based regimen
Maria M Santoro, Chiara Fornabaio, Marina Malena, et al.
International Journal of Antimicrobial Agents
|
July 17, 2018
Time spent with residual viraemia after virological suppression below 50 HIV-RNA copies/mL according to type of first-line antiretroviral regimen
Nicola Gianotti, Laura Galli, Nadia Galizzi, et al.
The Journal of Antimicrobial Chemotherapy
|
June 26, 2020
HIV-DNA undetectability during chronic HIV infection: frequency and predictive factors
Silvia Nozza, Laura Galli, Nicola Gianotti, et al.
Page
of 19